BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant
Open accessAbstract
against Death from the Delta Variant
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Effectiveness of ChAdOx1 against Delta variant-associated severe disease has been estimated at ≥80% in multiple postlicensure studies, including in India.
“Effectiveness of ChAdOx1 against Delta variant-associated severe disease has been estimated at ≥80% in multiple postlicensure studies63,64, including in India65.”
From Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city (2023) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Sheikh, A., McMenamin, J., Taylor, B., & Robertson, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01358-1 · Cited by 939 · see citing works
Self-citationVasileiou, E., Simpson, C. R., Shi, T., Kerr, S., Agrawal, U., Akbari, A., Bedston, S., Beggs, J., Bradley, D., Chuter, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00677-2 · Cited by 549 · see citing works
Self-citationClift, A. K., Coupland, C. A. C., Keogh, R. H., Diaz‐Ordaz, K., Williamson, E., Harrison, E. M., Hayward, A. C., Hemingway, H., Horby, P., Mehta, N., et al. (2020) · BMJ · doi:10.1136/bmj.m3731 · Cited by 533 · see citing works
Self-citationSimpson, C. R., Robertson, C., Vasileiou, E., McMenamin, J., Gunson, R. N., Ritchie, L. D., Woolhouse, M. E. J., Morrice, L., Kelly, D., Stagg, H. R., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039097 · Cited by 70 · see citing works
Self-citationCohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database
Mulholland, R. H., Vasileiou, E., Simpson, C. R., Robertson, C., Ritchie, L. D., Agrawal, U., Woolhouse, M. E. J., Murray, J., Stagg, H. R., Docherty, A. B., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab028 · Cited by 42 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Katikireddi, S. V., Cerqueira-Silva, T., Vasileiou, E., Robertson, C., Amele, S., Pan, J., Taylor, B., Boaventura, V., Werneck, G. L., Flores-Ortiz, R., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02754-9 · Cited by 124 · see citing works
Self-citationAttributed causes of excess mortality during the COVID-19 pandemic in a south Indian city
Lewnard, J. A., B, C. M., Kang, G., & Laxminarayan, R. (2023) · Nature Communications · doi:10.1038/s41467-023-39322-7 · Cited by 23 · see citing works
- Authors
- Sheikh, A., Robertson, C., & Taylor, B.
- Affiliations
- University of Edinburgh (GB)
- University of Strathclyde (GB)
- Public Health Scotland (GB)
- Corresponding author
- Sheikh, Aziz
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-12-02
- Volume
- 385
- Issue
- 23
- Pages
- 2195-2197
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC8552534
- OpenAlex
- W3205287879
- Cited by
- 101
- References
- 5
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 7 · 2023: 28 · 2022: 52 · 2021: 7
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council (MR/R008345/1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- BNT162b2, ChAdOx1 nCoV-19 vaccine, COVID-19 vaccines, vaccine effectiveness, Delta variant, COVID-19 mortality, Omicron variant
- MeSH terms
- COVID-19, SARS-CoV-2, Vaccine Efficacy, BNT162 Vaccine, ChAdOx1 nCoV-19, Adolescent, Adult, Electron Transport Complex IV, Female, Humans, Male, Middle Aged, Scotland, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
